Stay updated on Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T19:49:01.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The page shows a minor update: Revision v3.4.2 was added and Revision v3.4.1 was removed. This update affects only metadata and does not alter study content or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T02:31:34.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Platform revision from v3.4.0 to v3.4.1 with no visible changes to study content, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T00:00:44.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI and labeling updates include adding a glossary toggle, and capitalization/wording changes such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the version tag 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:40:38.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4 on the page.
    Difference
    0.0%
    Check dated 2026-01-14T04:05:59.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The Locations section has been reorganized: a single Locations heading now appears with the participating states (California, Connecticut, Florida, Georgia, Louisiana, Maryland, New York, North Carolina, Ohio, Pennsylvania, Washington), and per-state 'Locations' subsections were removed.
    Difference
    1%
    Check dated 2025-12-23T20:19:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Merkel Cell Cancer Clinical Trial page.